Publication Registration: |
Wednesday, October 1, 2003 |
Design Feature:
|
(1) Circles or ellipses containing one or more letters
(2) Circles or ellipses with inscriptions projecting beyond the circumference
(3) Ellipses
(4) Circles or ellipses with dark surfaces or parts of surfaces
(5) One circle or ellipse
(6) Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.
(7) Circles or ellipses with one or more triangles and/or lines forming an angle
(8) Letters presenting a special form of writing
(9) One letter
(10) Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.
|
Goods and Services Information
|
Description:
|
(1) - Biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; cell lines for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use as anti-infectives and anti-inflammatories and for the treatment of cancer and autoimmune diseases; cell lines for clinical, diagnostic and therapeutic use as anti-infectives and anti-inflammatories and for the treatment of cancer and autoimmune diseases; and animal embryos for laboratory use.
(2) - Pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for others.
(3) - Biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; cell lines for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use as anti-infectives and anti-inflammatories and for the treatment of cancer and autoimmune diseases; cell lines for clinical, diagnostic and therapeutic use as anti-infectives and anti-inflammatories and for the treatment of cancer and autoimmune diseases; and animal embryos for laboratory use.
(4) - Pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for others.
(5) - Biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; cell lines for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use as anti-infectives and anti-inflammatories and for the treatment of cancer and autoimmune diseases; cell lines for clinical, diagnostic and therapeutic use as anti-infectives and anti-inflammatories and for the treatment of cancer and autoimmune diseases; and animal embryos for laboratory use.
(6) - Pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for others.
|